Ticker Details
Omeros Corporation Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
IPO Date:	October 8, 2009
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$853.64M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.20%
Avg Daily Range (30 D):	$0.32 | 2.63%
Avg Daily Range (90 D):	$0.42 | 4.01%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	1.42M
Avg Daily Volume (90 D):	3.52M

Trade Size
Avg Trade Size (Sh.):	137
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	110

Institutional Trades
Total Institutional Trades:	1,325
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$1.16M
Avg Institutional Trade (90 D):	$1.36M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$1.21M
Avg Closing Trade (90 D):	$1.38M
Avg Closing Volume:	123.78K

News

Dec 24, 2025 @ 10:22 PM Why Omeros Stock Skyrocketed Today Source: Eric Volkman

Nov 5, 2025 @ 6:30 AM Novo Nordisk's sales increased by 12% in Danish kr... Source: Novo Nordisk

Oct 23, 2025 @ 12:35 PM Breakout Momentum Plays You Need to Know About Source: Nathan Reiff

Oct 22, 2025 @ 5:00 PM Complement 3 Glomerulopathy Market Poised for Phen... Source: Delveinsight

Apr 1, 2024 @ 7:35 AM Investor Sentiment Edges Lower, US Stocks Record G... Source: Avi Kapoor

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.03	$-.47	$-.43
Diluted EPS		$-.47	$-.43
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-121.16M	$-30.92M	$-25.42M
Operating Income / Loss	$-129.38M	$-26.39M	$-32.35M
Cost of Revenue
Net Cash Flow	$.87M	$.49M	$-2.36M
PE Ratio

Splits
Oct 02, 2009	25:49